Amgen Wins; Sanofi, Regeneron Lose Patent Case

Jan 06, 2017

Yahoo! Finance

A Delaware district court ruled that Sanofi and Regeneron Pharmaceuticals Inc. infringed the patents that competitor Amgen holds for its PCSK9 inhibitor, Repatha.

The decision blocks Sanofi and Regeneron from selling their drug Praluent in the United States. The injunction has been delayed for 30 days to allow the companies time to appeal, which they intend to do.

Amgen’s share rose close to 4 percent in after-hours trading on Thursday, according to Yahoo Finance.

Read the full story

Show Comments
Hide Comments

Join the discussion

We welcome your thoughtful comments.
All comments will display your user name.

Want to participate in the discussion?

Register for free

Log in for complete access.

Comments

No one has commented on this page yet.

RSS feed for comments on this page | RSS feed for all comments